Matches in Wikidata for { <http://www.wikidata.org/entity/Q66043588> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q66043588 description "assaig clínic" @default.
- Q66043588 description "clinical trial" @default.
- Q66043588 description "clinical trial" @default.
- Q66043588 description "clinical trial" @default.
- Q66043588 description "clinical trial" @default.
- Q66043588 description "ensaio clínico" @default.
- Q66043588 description "ensayo clínico" @default.
- Q66043588 description "ensayu clínicu" @default.
- Q66043588 description "essai clinique" @default.
- Q66043588 description "klinisch onderzoek" @default.
- Q66043588 description "клінічне випробування" @default.
- Q66043588 name "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 name "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 type Item @default.
- Q66043588 label "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 label "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 prefLabel "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 prefLabel "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 P1050 Q66043588-CC7D5076-065A-4E0A-9BC7-A51218359024 @default.
- Q66043588 P1050 Q66043588-EC35000D-0508-4114-A897-61FD2F5DAB51 @default.
- Q66043588 P1132 Q66043588-2EE44C21-70D2-49EF-83F5-EDCDFC3E343C @default.
- Q66043588 P1476 Q66043588-1837D377-B225-4D30-9C04-3A77C1F659AE @default.
- Q66043588 P17 Q66043588-5A85BD0C-4833-4E1D-9758-7EFF39DC5AB4 @default.
- Q66043588 P2899 Q66043588-DCC825B0-09F5-4755-9C07-0532121F5D0F @default.
- Q66043588 P3098 Q66043588-C6FD4C5C-4908-4EAD-8269-665F2B06971E @default.
- Q66043588 P31 Q66043588-456E1ABD-3BD0-4620-87D7-173A46A7FF4B @default.
- Q66043588 P580 Q66043588-6C66523D-AA5A-4AEC-86D2-4DFD7119B490 @default.
- Q66043588 P582 Q66043588-32B163A0-1D4E-4D94-A7E0-ECDE75ED6EB9 @default.
- Q66043588 P6099 Q66043588-ECB99860-9317-46B6-A2EF-3B79D593BB56 @default.
- Q66043588 P8363 Q66043588-C3510D20-8275-4013-8DC7-EF964050730B @default.
- Q66043588 P1050 Q1526459 @default.
- Q66043588 P1050 Q2119633 @default.
- Q66043588 P1132 "+5" @default.
- Q66043588 P1476 "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum" @default.
- Q66043588 P17 Q30 @default.
- Q66043588 P2899 "+18" @default.
- Q66043588 P3098 "NCT03137160" @default.
- Q66043588 P31 Q30612 @default.
- Q66043588 P580 "2017-05-04T00:00:00Z" @default.
- Q66043588 P582 "2018-08-16T00:00:00Z" @default.
- Q66043588 P6099 Q42824440 @default.
- Q66043588 P8363 Q78089383 @default.